Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer
Go back to Edgewise Therapeutics Appoints Marc Semigran, M.D., As Chief Development Officer| (NASDAQ: EWTX) | Delayed: 39.56 +0.41 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $39.15 | 52 Week High | $ | |||
| Open | $39.15 | 52 Week Low | $ | |||
| Day High | $39.81 | P/E | N/A | |||
| Day Low | $38.36 | EPS | $ | |||
| Volume | 793,163 | |||||

